Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

Candriam Equities L Life Care R2 USD Inc Fonds 58935083 / LU2223681979

155.73 USD
1.63 USD
1.06 %
30.1.2025
NAV

Nettoinventarwert (NAV)

155.73 USD 1.63 USD 1.06 %
Vortag 154.10 USD Datum 30.01.2025

Candriam Equities L Life Care R2 USD Inc Fonds Kurs - 1 Jahr

  • 1W
  • 3M
  • 1J
  • 3J
  • 5J
  • MAX

Top Kryptowährungen ETPs

Name ISIN Performance
21Shares Ripple XRP ETP CH0454664043 503.47%
21Shares Stellar ETP CH1109575535 355.68%
21Shares Algorand ETP CH1146882316 244.15%
21Shares Stacks Staking ETP CH1258969042 227.84%
21Shares Cardano ETP CH1102728750 182.48%
21Shares Sui Staking ETP CH1360612159 108.41%
21Shares Injective Staking ETP CH1360612134 7.60%
21Shares Immutable ETP CH1360612142 -16.40%
Name ISIN Performance
21Shares Sui Staking ETP CH1360612159 488.98%
21Shares Ripple XRP ETP CH0454664043 368.90%
21Shares Stellar ETP CH1109575535 301.40%
21Shares Aave ETP CH1135202120 207.97%
21Shares Algorand ETP CH1146882316 180.73%
21Shares Stacks Staking ETP CH1258969042 145.10%
21Shares Injective Staking ETP CH1360612134 -14.12%
21Shares Immutable ETP CH1360612142 -19.05%
Name ISIN Performance
21Shares Ripple XRP ETP CH0454664043 505.58%
21Shares Aave ETP CH1135202120 293.74%
21Shares Stellar ETP CH1109575535 278.72%
21Shares Crypto Basket Equal Weight (HODLV) ETP CH1135202161 237.73%
21Shares Crypto Mid-Cap Index ETP CH1130675676 164.02%
Name ISIN Performance
21Shares Solana staking ETP CH1114873776 993.02%
21Shares Ripple XRP ETP CH0454664043 643.59%
21Shares Crypto Basket Equal Weight (HODLV) ETP CH1135202161 368.71%
21Shares Bitcoin Core ETP CH1199067674 356.98%
21Shares Stellar ETP CH1109575535 355.59%

Fundamentaldaten

Valor 58935083
ISIN LU2223681979
Emittent Candriam
Aufgelegt in Luxembourg
Auflagedatum 11.01.2024
Kategorie Branchen: Gesundheitswesen
Währung USD
Volumen 688’511’809.19
Depotbank CACEIS Bank, Luxembourg Branch
Geschäftsjahresende 31.12.
Berichtsstand 30.01.2025

Anlagepolitik

So investiert der Candriam Equities L Life Care R2 USD Inc Fonds: The objective of the sub-fund is to benefit from the performance of the markets in equities of companies active in the pharmaceuticals, healthcare, medical technologies and biotechnology sectors, by investing in stocks of companies selected by the asset manager on the basis of their expected return, and to outperform the benchmark. This sub-fund invests primarily in equities, and/or securities equivalent to equities, of companies throughout the world which are active in the pharmaceuticals, healthcare, medical technologies and biotechnology sectors. It may also invest in companies with a high proportion of sales relating to the improvement of health conditions.

ETP Performance: Candriam Equities L Life Care R2 USD Inc Fonds

Performance 1 Jahr
4.29
Performance 2 Jahre -
Performance 3 Jahre -
Performance 5 Jahre -
Performance 10 Jahre -